AGIO Agios Pharmaceuticals, Inc. - Common Stock
À propos de Agios Pharmaceuticals, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Lire la suite
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
AGIO Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
AGIO Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
AGIO Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 5 31,2%
- Achat 7 43,8%
- Conserver 4 25,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-08-16Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-1.69 | $-1.70 | 0.01% |
| 31 mars 2026 | $-1.69 | $-1.84 | 0.15% |
| 31 décembre 2025 | $-1.86 | $-1.99 | 0.13% |
| 30 septembre 2025 | $-1.78 | $-1.94 | 0.16% |
| 30 juin 2025 | $-1.93 | $-1.84 | -0.09% |
| 31 mars 2025 | $-1.55 | $-1.82 | 0.27% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
Flux de trésorerie 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
Taux de croissance 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $54M | $36M | $27M | $14M | $0 |
| Marge d'exploitation % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Résultat net | $-413M | $674M | $-352M | $-232M | $1.60B |
| BPA dilué | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| Ratio de liquidité réduite | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-377M | $-392M | $-297M | $-314M | $-413M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 264 déclarants · $2.0B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 46 (+12 vs T. préc.) | 30 (-3 vs T. préc.) | 95 (+17 vs T. préc.) | 62 (-27 vs T. préc.) | +12.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219 594 714 | 5 917 400 | 11,17% | Actions |
| STATE STREET CORP | $131 144 972 | 3 533 633 | 6,67% | Actions |
| Lynx1 Capital Management LP | $126 505 652 | 3 408 937 | 6,43% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107 552 091 | 2 898 197 | 5,47% | Actions |
| ARMISTICE CAPITAL, LLC | $104 279 100 | 2 810 000 | 5,30% | Option d'achat |
| VANGUARD CAPITAL MANAGEMENT LLC | $99 523 268 | 2 681 845 | 5,06% | Actions |
| ARMISTICE CAPITAL, LLC | $89 064 000 | 2 400 000 | 4,53% | Actions |
| Erste Asset Management GmbH | $81 972 396 | 2 154 900 | 4,17% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78 332 000 | 2 110 809 | 3,98% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51 046 957 | 1 375 558 | 2,60% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $50 151 466 | 1 351 093 | 2,55% | Actions |
| ADAR1 Capital Management, LLC | $47 799 647 | 1 288 053 | 2,43% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $44 225 805 | 1 191 749 | 2,25% | Actions |
| GOLDMAN SACHS GROUP INC | $36 642 971 | 987 415 | 1,86% | Actions |
| D. E. Shaw & Co., Inc. | $34 087 168 | 918 544 | 1,73% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30 078 768 | 810 530 | 1,53% | Actions |
| Foresite Capital Management VI LLC | $29 131 350 | 785 000 | 1,48% | Actions |
| CITADEL ADVISORS LLC | $26 154 683 | 704 788 | 1,33% | Actions |
| Parkman Healthcare Partners LLC | $24 828 297 | 669 046 | 1,26% | Actions |
| SCS Capital Management LLC | $22 742 864 | 612 850 | 1,16% | Actions |
| Qube Research & Technologies Ltd | $22 178 346 | 597 638 | 1,13% | Actions |
| Defilade Capital Management, L.P. | $20 293 529 | 546 848 | 1,03% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19 969 930 | 538 128 | 1,02% | Actions |
| TWO SIGMA INVESTMENTS, LP | $19 905 062 | 536 380 | 1,01% | Actions |
| Rock Springs Capital Management LP | $19 763 413 | 532 563 | 1,01% | Actions |
| Schonfeld Strategic Advisors LLC | $19 300 279 | 520 083 | 0,98% | Actions |
| Point72 Asset Management, L.P. | $18 790 426 | 506 344 | 0,96% | Actions |
| JANE STREET GROUP, LLC | $18 280 312 | 492 598 | 0,93% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $14 690 661 | 395 868 | 0,75% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $13 876 579 | 373 931 | 0,71% | Actions |
| KENNEDY CAPITAL MANAGEMENT LLC | $13 850 565 | 373 230 | 0,70% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $13 342 901 | 359 550 | 0,68% | Actions |
| Squarepoint Ops LLC | $11 917 431 | 321 138 | 0,61% | Actions |
| JPMORGAN CHASE & CO | $11 853 074 | 309 008 | 0,60% | Actions |
| Ensign Peak Advisors, Inc | $11 045 049 | 297 630 | 0,56% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $9 996 803 | 269 383 | 0,51% | Actions |
| ALGERT GLOBAL LLC | $9 203 540 | 248 007 | 0,47% | Actions |
| JANE STREET GROUP, LLC | $7 974 939 | 214 900 | 0,41% | Option de vente |
| Palo Alto Investors LP | $7 926 733 | 213 601 | 0,40% | Actions |
| Tetragon Partners GP Ltd | $7 629 037 | 205 579 | 0,39% | Actions |
| AXA Investment Managers S.A. | $7 131 875 | 177 675 | 0,36% | Actions |
| Cutter Capital Management, LP | $6 895 755 | 235 350 | 0,35% | Actions |
| BlackRock, Inc. | $6 545 388 | 176 378 | 0,33% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 334 677 | 170 700 | 0,32% | Option d'achat |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6 306 139 | 169 931 | 0,32% | Actions |
| FIRST TRUST ADVISORS LP | $6 144 933 | 165 587 | 0,31% | Actions |
| Ishara Investments LP | $6 086 040 | 164 000 | 0,31% | Actions |
| GROUP ONE TRADING LLC | $5 640 497 | 151 994 | 0,29% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $5 562 269 | 149 886 | 0,28% | Actions |
| BANK OF AMERICA CORP /DE/ | $5 505 083 | 148 345 | 0,28% | Actions |
| MARSHALL WACE, LLP | $5 150 868 | 138 800 | 0,26% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 080 359 | 136 900 | 0,26% | Option de vente |
| AMERICAN CENTURY COMPANIES INC | $4 991 740 | 134 512 | 0,25% | Actions |
| Man Group plc | $4 617 931 | 124 439 | 0,23% | Actions |
| ArrowMark Colorado Holdings LLC | $4 368 367 | 117 714 | 0,22% | Actions |
| Pictet Asset Management Holding SA | $4 247 606 | 111 861 | 0,22% | Actions |
| Swiss National Bank | $4 143 703 | 111 660 | 0,21% | Actions |
| CAPITAL FUND MANAGEMENT S.A. | $3 862 408 | 104 080 | 0,20% | Actions |
| Assenagon Asset Management S.A. | $3 857 770 | 103 955 | 0,20% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3 700 831 | 99 726 | 0,19% | Actions |
| Knott David M Jr | $3 527 602 | 95 058 | 0,18% | Actions |
| Trexquant Investment LP | $3 471 232 | 93 539 | 0,18% | Actions |
| CITADEL ADVISORS LLC | $3 402 987 | 91 700 | 0,17% | Option d'achat |
| Jain Global LLC | $3 401 020 | 91 647 | 0,17% | Actions |
| Caligan Partners LP | $3 339 900 | 90 000 | 0,17% | Option d'achat |
| CITADEL ADVISORS LLC | $3 295 368 | 88 800 | 0,17% | Option de vente |
| CITIGROUP INC | $3 182 331 | 85 754 | 0,16% | Actions |
| RHUMBLINE ADVISERS | $2 948 045 | 79 441 | 0,15% | Actions |
| Bank of New York Mellon Corp | $2 916 846 | 78 600 | 0,15% | Actions |
| Campbell & CO Investment Adviser LLC | $2 712 555 | 73 095 | 0,14% | Actions |
| Exome Asset Management LLC | $2 616 255 | 70 500 | 0,13% | Actions |
| Edgestream Partners, L.P. | $2 604 936 | 70 195 | 0,13% | Actions |
| TUDOR INVESTMENT CORP ET AL | $2 441 059 | 65 779 | 0,12% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 319 520 | 68 564 | 0,12% | Actions |
| TWO SIGMA ADVISERS, LP | $2 319 144 | 85 200 | 0,12% | Actions |
| ALPS ADVISORS INC | $2 228 789 | 60 059 | 0,11% | Actions |
| Seven Fleet Capital Management LP | $2 111 559 | 56 900 | 0,11% | Actions |
| ALLIANCEBERNSTEIN L.P. | $2 092 859 | 61 864 | 0,11% | Actions |
| Rafferty Asset Management, LLC | $2 062 574 | 55 580 | 0,10% | Actions |
| Engineers Gate Manager LP | $2 000 674 | 53 912 | 0,10% | Actions |
| WELLS FARGO & COMPANY/MN | $1 935 843 | 52 165 | 0,10% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 931 576 | 52 050 | 0,10% | Actions |
| XTX Topco Ltd | $1 869 082 | 50 366 | 0,10% | Actions |
| Caption Management, LLC | $1 855 500 | 50 000 | 0,09% | Option d'achat |
| Tetragon Partners GP Ltd | $1 855 500 | 50 000 | 0,09% | Option d'achat |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1 846 742 | 49 764 | 0,09% | Actions |
| BARCLAYS PLC | $1 725 651 | 46 501 | 0,09% | Actions |
| Quantinno Capital Management LP | $1 614 805 | 43 514 | 0,08% | Actions |
| MARTINGALE ASSET MANAGEMENT L P | $1 596 064 | 43 009 | 0,08% | Actions |
| IEQ CAPITAL, LLC | $1 499 392 | 40 404 | 0,08% | Actions |
| Kodai Capital Management LP | $1 485 276 | 50 692 | 0,08% | Actions |
| Virtus Investment Advisers, LLC | $1 464 843 | 39 473 | 0,07% | Actions |
| Caption Management, LLC | $1 456 530 | 39 249 | 0,07% | Actions |
| JANE STREET GROUP, LLC | $1 451 001 | 39 100 | 0,07% | Option d'achat |
| FMR LLC | $1 446 325 | 38 974 | 0,07% | Actions |
| Aquatic Capital Management LLC | $1 433 448 | 38 627 | 0,07% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 400 049 | 37 727 | 0,07% | Actions |
| VANGUARD GROUP INC | $1 308 928 | 48 087 | 0,07% | Actions |
| EDGEWOOD MANAGEMENT LLC | $1 298 850 | 35 000 | 0,07% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 298 776 | 34 998 | 0,07% | Actions |
Initiés de la société 33 initiés · 12 dirigeants · 19 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 juin 2026 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 18 juin 2026 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 avril 2019 A | 12 374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 4 janvier 2016 M | 120 834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 juin 2026 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 18 juin 2026 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 18 juin 2026 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 5 avril 2019 M | 26 511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 1 avril 2019 M | 7 238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 4 mars 2019 M | 10 941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 22 février 2019 A | 2 796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 février 2016 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | Administrateur | 18 juin 2026 A | 10 865 | 0 | 0 | $0 |
| Rahul D. Ballal | Administrateur | 18 juin 2026 A | 15 230 | 0 | 0 | $0 |
| David Scadden | Administrateur | 18 juin 2026 A | 20 419 | 0 | 0 | $0 |
| Maykin Ho | Administrateur | 18 juin 2026 A | 19 848 | 0 | 0 | $0 |
| Cynthia Smith | Administrateur | 18 juin 2026 A | 15 230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Administrateur | 18 juin 2026 A | 154 156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | Administrateur | 18 juin 2026 A | 10 284 | 0 | 0 | $0 |
| Jeffrey D Capello | Administrateur | 18 juin 2026 A | 10 865 | 0 | 0 | $0 |
| Paul J Clancy | Administrateur | 31 mai 2019 M | 1 400 | 0 | 0 | $0 |
| Ian T Clark | Administrateur | 31 mai 2019 M | 1 400 | 0 | 0 | $0 |
| John Maraganore | Administrateur | 31 mai 2019 M | 37 609 | 0 | 0 | $0 |
| David P Schenkein | Administrateur | 22 février 2019 A | 89 503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | Administrateur | 7 décembre 2017 S | 79 515 | 0 | 0 | $0 |
| Robert Nelsen | Administrateur | 6 mars 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | Administrateur | 10 août 2016 J | 2 778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Administrateur | 21 juin 2016 A | 101 009 | 0 | 0 | $0 |
| Perry A Karsen | Administrateur | 23 juin 2015 A | — | 0 | 0 | $0 |
| Kevin P Starr | Administrateur | 19 février 2015 J | 184 386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | Détenteur de 10% | 16 décembre 2014 P | 1 231 778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 4 août 2026 S | 54 645 | 0 | 2 | $-1 064 903 |
| Jay T. Backstrom | — | 8 juillet 2026 M | 1 447 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 5 avril 2021 | — | Dépôt initial | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 dépôts | 14 novembre 2019 | — | Dépôt initial | Structure du capital | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 dépôts | 17 décembre 2014 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 57 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 34 703 NS | 30 avril 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,10% | 60 392 NS | 31 mai 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,77% | 43 269 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,60% | 110 585 NS | 30 avril 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 3 805 SH | 8 août 2026 | Quotidien |
| AGNG · Global X Funds | 0,28% | 7 695 NS | 31 mai 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 101 599 NS | 30 avril 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 17 290 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,14% | 408 719 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3 239 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 48 730 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,13% | 113 617 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,12% | 109 727 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,11% | 515 162 SH | 8 août 2026 | Quotidien |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 40 934 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2 166 NS | 31 mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 22 172 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 340 226 SH | 8 août 2026 | Quotidien |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 788 655 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,06% | 1 508 427 SH | 8 août 2026 | Quotidien |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 9 472 NS | 30 avril 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 48 207 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,05% | 24 449 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2 658 NS | 31 mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 193 306 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 280 734 NS | 31 mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10 195 SH | 8 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1 364 364 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,03% | 167 169 SH | 8 août 2026 | Quotidien |
| ISCB · iShares Trust | 0,03% | 2 463 SH | 8 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 25 231 NS | 30 avril 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2 079 NS | 31 mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5 020 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 683 802 SH | 8 août 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,02% | 2 762 NS | 30 avril 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 2 105 NS | 31 mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5 903 NS | 31 mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3 329 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3 639 SH | 8 août 2026 | Quotidien |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2 328 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 136 570 NS | 30 avril 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 8 867 NS | 30 avril 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 53 NS | 31 mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25 095 NS | 31 mai 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 30 958 SH | 8 août 2026 | Quotidien |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1 068 NS | 31 mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4 329 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17 627 NS | 30 avril 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 19 324 NS | 30 avril 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16 536 SH | 8 août 2026 | Quotidien |